SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hans U. Tschanz who wrote (28)2/15/2000 8:51:00 AM
From: swisstrader  Read Replies (1) of 598
 
Hans: more on Ebner holdings...I believe the answer is that TLRK represents 13% of HIS V2000 portfolio (includes Roche, Glaxo, etc) vs. his owning 15-20% of T....may also wish to check out the following link on Ebner's V2000, which includes his asset allocation and a write up of why he's involved with TLRK...also, for those of you who don't know who Ebner is, perhaps you can tell folks:

ebner.ch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News